LARISA NERETINA: Open Payments
NPI 1063818441 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,427 in 69 payments from 24 companies in 2025. Trend: 2023 $1,115 · 2024 $1,084 · 2025 $1,427
Food & beverage: $1,427
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $257 |
| Tandem Diabetes Care, Inc. | 6 | $100 |
| Insulet Corporation | 4 | $94 |
| Amgen Inc. | 5 | $92 |
| Mannkind Corporation | 5 | $90 |
| Corcept Therapeutics | 3 | $72 |
| Dexcom, Inc. | 3 | $69 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $68 |
| BETA BIONICS, INC. | 4 | $65 |
| Ascendis Pharma Endocrinology Inc | 3 | $63 |
Products named: t:slim X2 Insulin Pump with Control-IQ, Omnipod, AFREZZA, Ozempic, Wegovy, Korlym, Dexcom G6 Transmitter, ISTURISA.
Industry payments across TX — which companies pay providers there.
